对老年患者CDKI相关不良事件的比较分析:来自FDA不良事件报告系统数据库的真实数据
Qiongtong Fang1, Fuqiang Huang2, Huibin Zhao1
1Department of Pharmacy, The Fifth Affiliated Hospital of SUN YAT-SEN University, Zhuhai, China.
Expert opinion on drug safety
|March 19, 2025
概括
循环素依赖性激酶4和6抑制剂 (CDKI) 在老年乳腺癌患者中显示安全性. 现实世界的数据分析确定了预期和意想不到的不良事件,突出了进一步临床研究的需要.
科学领域:
- 在瘤学瘤学.
- 药物监督 药物监督 药物监督
- 老年医学 老年医学
背景情况:
- 循环素依赖性激酶4和6抑制剂 (CDKI) 是已确立的高级和转移性乳腺癌的治疗方法.
- 对于CDKI在老年患者群体中的安全性数据有限.
- 本研究分析了老年人FDA不良事件报告系统 (FAERS) 的安全数据.
研究的目的:
- 评估CDKIs在患有晚期和转移性乳腺癌的老年患者中的安全性.
- 在这个人口群体中识别与abemaciclib,palbociclib和ribociclib相关的潜在药物相关不良事件 (AE).
- 在老年人中比较不同CDKI的AE概况.
主要方法:
- 使用FDA FAERS数据库进行了不成比例分析.
- 在老年患者中分析了abemaciclib,palbociclib和ribociclib的病例报告.
- 药物-AE信号被识别并按器官系统类别 (SOC) 分类.
主要成果:
- 分析包括分别为abemaciclib,palbociclib和ribociclib的2132,36916和4328个病例报告.
- 对于所有CDKI来说,观察到恶心,中性质衰竭和疲劳等预期的副作用.
- 值得注意的副作用包括间歇性肺病,血栓塞栓事件和心脏毒性. 还发现了急性损伤,心房动和记忆障碍等意想不到的信号.
结论:
- 这些发现与对老年人CDKI相关副作用的临床观察一致.
- 该研究确定了与CDKI相关的预期和意外不良事件.
- 建议进行进一步的临床研究,以确认老年人群中CDKI之间的AE差异.
更多相关视频
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
14.3K
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.1K
相关概念视频
Pharmacovigilance
762
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
762
Clinical Trials: Overview
2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Factors Affecting Drug Response: Overview
1.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
110
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
110
